Analyst Barton Crockett from FBR Capital downgraded his rating on Time Warner Inc (NYSE:TWX) to a Market Perform rating with a price target …
FBR Capital analyst Vernon Bernardino weighed in on Pluristem Therapeutics Inc. (NASDAQ:PSTI) following the an announcement that the company plans to initiate a Phase I trial to …
Healthcare analysts weighed in today on small biopharmaceutical firms Relypsa Inc (NASDAQ:RLYP) and Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), following meeting with management and Phase II clinical trial …
Analysts are weighing in today on chip maker Advanced Micro Devices, Inc. (NASDAQ:AMD), video-streaming company Netflix, Inc.
FBR Capital analyst Carter Driscoll came out yesterday with new ratings and price targets on a handful of energy stocks. Lets take a look and …
Considerable strength remains visible among biotechnology stocks, as reflected by the 2.25 percent gain being posted by the iShares NASDAQ Biotechnology Index today.
Analysts at Piper Jaffray and FBR Capital weigh in on the online media giant Yahoo! Inc.
Shares of oil and gas production company Breitburn Energy Partners LP (NASDAQ:BBEP) and upstream energy company Linn Energy LLC (NASDAQ:LINE) have been under pressure, dropping 35% and 10.50%, …
In a research report released today, FBR Capital analyst Bob Ramsey reiterated an Outperform rating on shares of On Deck Capital Inc (NYSE:ONDK), with …
Stifel and FBR Capital analysts came out today with new ratings and price targets on a handful of healthcare stocks. Lets take a look …
